Investing.com - Medtronic (NYSE:MDT) reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Medtronic announced earnings per share of $1.30 on revenue of $7.6B. Analysts polled by Investing.com anticipated EPS of $1.28 on revenue of $7.7B.
Medtronic shares are down 20% from the beginning of the year and are trading at $82.29 , down-from-52-week-high.
Medtronic follows other major Healthcare sector earnings this month
Medtronic's report follows an earnings beat by Eli Lilly on November 1, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
AbbVie had beat expectations on October 28 with third quarter EPS of $3.66 on revenue of $14.81B, compared to forecast for EPS of $3.58 on revenue of $14.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar